APA (7th ed.) Citation

Chen R & Chen B. (2015). Siltuximab (CNTO 328): A promising option for human malignancies. Dove Medical Press.

Chicago Style (17th ed.) Citation

Chen R and Chen B. Siltuximab (CNTO 328): A Promising Option For human Malignancies. Dove Medical Press, 2015.

MLA (9th ed.) Citation

Chen R and Chen B. Siltuximab (CNTO 328): A Promising Option For human Malignancies. Dove Medical Press, 2015.

Warning: These citations may not always be 100% accurate.